Biopharmaceutical production faces the challenge of ensuring the quality of raw materials due to a lack of specific guidelines. By implementing effective risk assessment strategies and working with reliable, selected solution providers, biopharmaceutical manufacturers can minimize these challenges and improve product quality.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

LenioBio and Labscoop’s Strategic Partnership Aimed at Enhancing Access to Cell-Free Protein Synthesis

By Feliza Mirasol

July 3rd 2024

A strategic partnership between LenioBio and Labscoop is aimed at making scalable cell-free protein synthesis technology more accessible across North America.

Syngene Launches Rapid Protein Synthesis Platform

By Feliza Mirasol

June 12th 2024

Syngene has launched a new protein production platform that offers faster production with lower risk.

Twist Bioscience Launches Gene Synthesis Service

By Feliza Mirasol

November 16th 2023

Twist Bioscience now offers its Express Genes rapid gene synthesis service at its Wilsonville, Ore., manufacturing facility.

Orano Med and Orbit Discovery Enter Collaboration for New Novel Targeted Radioligand Therapies

By Jill Murphy

September 11th 2023

The agreement states that Orbit will implement its bead-based peptide display engine to discover peptide leads specific to targets related to specific tumors.

<1 2 3 4 5 6

About Us

Advertise

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777